Skip to main content
. 2016 Apr 20;11(6):3821–3828. doi: 10.3892/ol.2016.4476

Figure 2.

Figure 2.

Associated network in nasopharyngeal carcinoma. MIR, microRNA; miR, microRNA; hsa, Homo sapiens; HG, host gene; MAD2L1, mitotic arrest deficient-like 1; TGFB3, transforming growth factor, beta 3; CDH1, cadherin 1; ZEB1, zinc finger E-box binding homeobox 1; EGFR, epidermal growth factor receptor; CCND1, cyclin D1; PDLIM7, PDZ and LIM domain 7 (enigma); RBL2, retinoblastoma-like 2; TP63, tumor protein p63; CADM1, cell adhesion molecule 1; BCL2, B-cell lymphoma 2; TGFBR2, transforming growth factor, beta receptor II; BMI1, B lymphoma Mo-MLV insertion region 1 homolog; TLR4, Toll-like receptor 4; E2F1, E2F transcription factor 1; CDKN2A, cyclin-dependent kinase inhibitor 2A; CTNNB1, catenin beta 1; MYC, v-Myc avian myelocytomatosis viral oncogene homolog; KRAS, Kirsten rat sarcoma viral oncogene homolog; BCL2L11, BCL2-like 11; HIF1A, hypoxia inducible factor 1, alpha subunit; RASSF, Ras association domain family; BPIFA1, bactericidal permeability-increasing fold containing family A, member 1; UBAP1, ubiquitin associated protein 1; BCL3, B-cell lymphoma 3.